Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders

Regulation of dopaminergic neural transmission by tyrosine hydroxylase protein at nerve terminals

Chiho Ichinose, Hiroshi Ichinose, Kazuhisa Ikemoto, Takahide Nomura, Kazunao Kondo

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

5R-L-Erythro-5,6,7,8-tetrahydrobiopterin (BH4) is an essential cofactor for tyrosine hydroxylase (TH). Recently, a type of dopa-responsive dystonia (DRD) (DYT5, Segawa's disease) was revealed to be caused by dominant mutations of the gene encoding GTP cyclohydrolase I (GCHI), which is the rate-limiting enzyme of BH4 biosynthesis. In order to probe the role of BH4 in vivo, we established BH4-depleted mice by disrupting the 6-pyruvoyltetrahydropterin synthase (PTS) gene (Pts-/-) and rescued them by introducing human PTS cDNA under the control of the human dopamine β-hydroxylase (DBH) promoter (Pts-/--DPS). The Pts-/--DPS mice developed hyperphenylalaninemia. Interestingly, tyrosine hydroxylase protein was dramatically reduced in the dopaminergic nerve terminals of these mice, and they developed abnormal posture and motor disturbance. We propose that the biochemical and pathologic changes of Pts-/--DPS mice are caused by mechanisms common to human DRD, and understanding these mechanisms could give us insight into other movement disorders.

Original languageEnglish
Pages (from-to)17-24
Number of pages8
JournalJournal of Pharmacological Sciences
Volume114
Issue number1
DOIs
Publication statusPublished - 21-10-2010

Fingerprint

Tyrosine 3-Monooxygenase
Mental Disorders
Synaptic Transmission
Dopamine
Research
Pharmaceutical Preparations
Proteins
GTP Cyclohydrolase
Dominant Genes
Phenylketonurias
Movement Disorders
Mixed Function Oxygenases
Posture
Complementary DNA
Mutation
Enzymes
Genes
6-pyruvoyltetrahydropterin synthase
Dopa-Responsive Dystonia

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Molecular Medicine

Cite this

@article{3f9940f842034da59008b3444540efbc,
title = "Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: Regulation of dopaminergic neural transmission by tyrosine hydroxylase protein at nerve terminals",
abstract = "5R-L-Erythro-5,6,7,8-tetrahydrobiopterin (BH4) is an essential cofactor for tyrosine hydroxylase (TH). Recently, a type of dopa-responsive dystonia (DRD) (DYT5, Segawa's disease) was revealed to be caused by dominant mutations of the gene encoding GTP cyclohydrolase I (GCHI), which is the rate-limiting enzyme of BH4 biosynthesis. In order to probe the role of BH4 in vivo, we established BH4-depleted mice by disrupting the 6-pyruvoyltetrahydropterin synthase (PTS) gene (Pts-/-) and rescued them by introducing human PTS cDNA under the control of the human dopamine β-hydroxylase (DBH) promoter (Pts-/--DPS). The Pts-/--DPS mice developed hyperphenylalaninemia. Interestingly, tyrosine hydroxylase protein was dramatically reduced in the dopaminergic nerve terminals of these mice, and they developed abnormal posture and motor disturbance. We propose that the biochemical and pathologic changes of Pts-/--DPS mice are caused by mechanisms common to human DRD, and understanding these mechanisms could give us insight into other movement disorders.",
author = "Chiho Ichinose and Hiroshi Ichinose and Kazuhisa Ikemoto and Takahide Nomura and Kazunao Kondo",
year = "2010",
month = "10",
day = "21",
doi = "10.1254/jphs.09R28FM",
language = "English",
volume = "114",
pages = "17--24",
journal = "Journal of Pharmacological Sciences",
issn = "1347-8613",
publisher = "Japanese Pharmacological Society",
number = "1",

}

Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders : Regulation of dopaminergic neural transmission by tyrosine hydroxylase protein at nerve terminals. / Ichinose, Chiho; Ichinose, Hiroshi; Ikemoto, Kazuhisa; Nomura, Takahide; Kondo, Kazunao.

In: Journal of Pharmacological Sciences, Vol. 114, No. 1, 21.10.2010, p. 17-24.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders

T2 - Regulation of dopaminergic neural transmission by tyrosine hydroxylase protein at nerve terminals

AU - Ichinose, Chiho

AU - Ichinose, Hiroshi

AU - Ikemoto, Kazuhisa

AU - Nomura, Takahide

AU - Kondo, Kazunao

PY - 2010/10/21

Y1 - 2010/10/21

N2 - 5R-L-Erythro-5,6,7,8-tetrahydrobiopterin (BH4) is an essential cofactor for tyrosine hydroxylase (TH). Recently, a type of dopa-responsive dystonia (DRD) (DYT5, Segawa's disease) was revealed to be caused by dominant mutations of the gene encoding GTP cyclohydrolase I (GCHI), which is the rate-limiting enzyme of BH4 biosynthesis. In order to probe the role of BH4 in vivo, we established BH4-depleted mice by disrupting the 6-pyruvoyltetrahydropterin synthase (PTS) gene (Pts-/-) and rescued them by introducing human PTS cDNA under the control of the human dopamine β-hydroxylase (DBH) promoter (Pts-/--DPS). The Pts-/--DPS mice developed hyperphenylalaninemia. Interestingly, tyrosine hydroxylase protein was dramatically reduced in the dopaminergic nerve terminals of these mice, and they developed abnormal posture and motor disturbance. We propose that the biochemical and pathologic changes of Pts-/--DPS mice are caused by mechanisms common to human DRD, and understanding these mechanisms could give us insight into other movement disorders.

AB - 5R-L-Erythro-5,6,7,8-tetrahydrobiopterin (BH4) is an essential cofactor for tyrosine hydroxylase (TH). Recently, a type of dopa-responsive dystonia (DRD) (DYT5, Segawa's disease) was revealed to be caused by dominant mutations of the gene encoding GTP cyclohydrolase I (GCHI), which is the rate-limiting enzyme of BH4 biosynthesis. In order to probe the role of BH4 in vivo, we established BH4-depleted mice by disrupting the 6-pyruvoyltetrahydropterin synthase (PTS) gene (Pts-/-) and rescued them by introducing human PTS cDNA under the control of the human dopamine β-hydroxylase (DBH) promoter (Pts-/--DPS). The Pts-/--DPS mice developed hyperphenylalaninemia. Interestingly, tyrosine hydroxylase protein was dramatically reduced in the dopaminergic nerve terminals of these mice, and they developed abnormal posture and motor disturbance. We propose that the biochemical and pathologic changes of Pts-/--DPS mice are caused by mechanisms common to human DRD, and understanding these mechanisms could give us insight into other movement disorders.

UR - http://www.scopus.com/inward/record.url?scp=77957953665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957953665&partnerID=8YFLogxK

U2 - 10.1254/jphs.09R28FM

DO - 10.1254/jphs.09R28FM

M3 - Article

VL - 114

SP - 17

EP - 24

JO - Journal of Pharmacological Sciences

JF - Journal of Pharmacological Sciences

SN - 1347-8613

IS - 1

ER -